Dhanaraj V, Ye Q Z, Johnson L L, Hupe D J, Ortwine D F, Dunbar J B, Rubin J R, Pavlovsky A, Humblet C, Blundell T L
Department of Crystallography, Birkbeck College, London, UK.
Structure. 1996 Apr 15;4(4):375-86. doi: 10.1016/s0969-2126(96)00043-3.
Stromelysin belongs to a family of zinc-dependent endopeptidases referred to as matrix metalloproteinases (MMPs, matrixins) because of their capacity for selective degradation of various components of the extracellular matrix. Matrixins play key roles in diseases as diverse as arthritis and cancer and hence are important targets for therapeutic intervention.
The crystal structure of the stromelysin catalytic domain (SCD) with bound hydroxamate inhibitor, solved by multiple isomorphous replacement, shows deep S1' specificity pocket which explains differences in inhibitors binding between the collagenases and stromelysin. The binding of calcium ions by loops at the two ends of a beta-strand which marks the boundary of the active site provides a structural rationale for the importance of these cations for stability and catalytic activity. Major differences between the matrixins are clustered in two regions forming the entrance to the active site and hence may be determinants of substrate selectivity.
Structural comparisons of SCD with representative members of the metalloproteinase superfamily clearly highlight the conservation of key secondary structural elements, in spite of major variations in the sequences including insertions and deletions of functional domains. However, the three-dimensional structure of SCD, which is generally closely related to the collagenases, shows significant differences not only in the peripheral regions but also in the specificity pockets; these latter differences should facilitate the rational design of specific inhibitors.
基质溶素属于锌依赖性内肽酶家族,因其能够选择性降解细胞外基质的各种成分而被称为基质金属蛋白酶(MMPs,基质酶)。基质酶在诸如关节炎和癌症等多种疾病中发挥关键作用,因此是治疗干预的重要靶点。
通过多同晶置换解析得到的与异羟肟酸抑制剂结合的基质溶素催化结构域(SCD)的晶体结构显示出较深的S1'特异性口袋,这解释了胶原酶和基质溶素之间抑制剂结合的差异。在标记活性位点边界的β链两端的环与钙离子的结合为这些阳离子对稳定性和催化活性的重要性提供了结构依据。基质酶之间的主要差异集中在形成活性位点入口的两个区域,因此可能是底物选择性的决定因素。
SCD与金属蛋白酶超家族代表性成员的结构比较清楚地突出了关键二级结构元件的保守性,尽管序列存在包括功能域插入和缺失在内的主要变化。然而,通常与胶原酶密切相关的SCD三维结构不仅在外围区域而且在特异性口袋中都显示出显著差异;后者的这些差异应有助于合理设计特异性抑制剂。